#UNAIDS

Although we have the tools to end the epidemic through treatment and PrEP, costs and other considerations limit these methods.

With the President’s Emergency Plan for AIDS Relief budget up in the air, advocates worry that PEPFAR will cap HIV treatment elsewhere.

An increasing proportion of those living with HIV are in care and on successful treatment, but there is still much room for improvement.

HIV scientists and advocates are waging a powerful war against the global epidemic.

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

Highly precise analyses of diagnosis and treatment statistics in hard-hit Zambia, Zimbabwe and Malawi reveal crucial disparities.

“We are at a tipping point in the fight against AIDS, with a quickly closing window of opportunity.”

The agency has issued an urgent call to nations to implement steps to ward off this threat to progress in fighting the epidemic.

A massive national campaign to step up testing as well as viral suppression achieved phenomenal results in just five years.

For the first time, more than half of people with HIV are taking meds. The analysis also shows troubling trends in the former Soviet region.

The HIV population in Western and Southern Europe is nearing the United Nations’ “90-90-90” goals for tackling the epidemic.

Why an even partially effective HIV vaccine could be key to beating the global pandemic

With a major new HIV vaccine trial under way, cautious optimism is stirring that the vaccine will prove effective enough for a rollout.

The 90-90-90 targets are likely unattainable because of the high proportion of those living with HIV in remote areas in Africa.

With a likely increasing proportion of the HIV population virally suppressed, addressing disparities, especially racial ones, is vital.

A look at the most notable HIV-related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle.